Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan · Delayed Price · Currency is JPY 1,880.50
-35.50 (-1.85%)
Aug 19, 2026, 3:30 PM JST
Santen Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 291,844 | 291,624 | 300,004 | 301,965 | 279,037 | 266,257 |
Revenue Growth | -0.72% | -2.79% | -0.65% | 8.22% | 4.80% | 6.67% |
Gross Profit Gross Profit Growth | 172,612 | 169,743 | 171,027 | 178,709 | 166,087 | 156,586 |
Operating Income Operating Income Growth | 46,768 | 46,224 | 48,295 | 52,185 | 35,300 | 35,875 |
Net Income Net Income Growth | 38,676 | 37,360 | 36,247 | 26,634 | -14,955 | 27,212 |
Earnings Per Share EPS Growth | 119.40 | 113.80 | 103.68 | 72.37 | -38.60 | 67.97 |
EPS Growth | 30.63% | 9.76% | 43.26% | - | - | 298.44% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Japan Japan Growth | 146,812 | 165,310 | 175,608 | 177,373 | 173,633 |
China China Growth | 30,011 | 28,927 | 29,858 | 21,546 | 27,197 |
Asia (Exclude China) Asia (Exclude China) Growth | 33,252 | 30,097 | 28,666 | 24,118 | 19,813 |
Europe, Middle East and Africa (EMEA) Europe, Middle East and Africa (EMEA) Growth | 80,097 | 74,322 | 64,756 | 52,513 | 42,899 |
Others Others Growth | 1,451 | 1,349 | - | - | - |
Total Total Growth | 291,623 | 300,005 | 301,966 | 279,038 | 266,257 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 78,258 | 80,875 | 92,997 | 94,582 | 57,903 | 83,014 |
Total Debt Total Debt Growth | - | 34,752 | 34,229 | 34,610 | 36,207 | 32,932 |
Net Cash (Debt) Net Cash Growth | 78,258 | 46,123 | 58,768 | 59,972 | 21,696 | 50,082 |
Net Cash Growth | -7.47% | -21.52% | -2.01% | 176.42% | -56.68% | -5.04% |
Net Cash Per Share Net Cash Per Share Growth | 243.65 | 140.46 | 168.06 | 162.91 | 56.00 | 125.06 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 41,038 | 43,500 | 60,928 | 72,649 | 37,147 | 46,043 |
Capital Expenditures CapEx Growth | -5,940 | -6,844 | -6,662 | -9,319 | -17,277 | -17,344 |
Free Cash Flow Free Cash Flow Growth | 35,098 | 36,656 | 54,266 | 63,330 | 19,870 | 28,699 |
Free Cash Flow Growth | -27.73% | -32.45% | -14.31% | 218.72% | -30.76% | -17.22% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | - | 58.21% | 57.01% | 59.18% | 59.52% | 58.81% |
Operating Margin | 16.02% | 15.85% | 16.10% | 17.28% | 12.65% | 13.47% |
Pretax Margin | 16.56% | 16.27% | 15.83% | 9.89% | -2.08% | 13.38% |
Profit Margin | 13.25% | 12.81% | 12.08% | 8.82% | -5.36% | 10.22% |
FCF Margin | 12.03% | 12.57% | 18.09% | 20.97% | 7.12% | 10.78% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 42.000 | 38.000 | 36.000 | 33.000 | 32.000 | 32.000 |
Dividend Per Share Growth | 5.26% | 5.56% | 9.09% | 3.13% | 0% | 14.29% |
Dividend Yield | 2.19% | 2.13% | 2.60% | 2.25% | 3.03% | 2.88% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 16.05 | 15.37 | 13.35 | 21.00 | - | 18.04 |
Forward PE | 15.16 | 16.06 | 14.12 | 17.09 | 25.03 | 16.26 |
P/FCF Ratio | 17.53 | 15.67 | 8.92 | 8.83 | 21.36 | 17.11 |
PS Ratio | 2.11 | 1.97 | 1.61 | 1.85 | 1.52 | 1.84 |